Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-13

Clinical Trial Update: A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel [NA]

View source ↗

Summary

A clinical trial update indicates the study evaluating real-time pressure controllers to alleviate peripheral neuropathy symptoms in breast cancer patients trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Real Time Pressure Controller, Breast Cancer | NA | Status: RECRUITING